Orazio Fortunato

7PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
Immune Regulation and the Role of Extracellular Vesicles in Non-Small Cell Lung Cancer: Biological Mechanisms and Therapeutic Perspectives.

|Oct 14, 2023
Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling.

Ilaria Petraroia, Patrizia Ghidotti, Giulia Bertolini

|Nov 26, 2022
MiR-223 Exclusively Impairs In Vitro Tumor Growth through IGF1R Modulation in Rhabdomyosarcoma of Adolescents and Young Adults.

Michela Casanova, Francesca Pontis, Patrizia Ghidotti

|Sep 16, 2022
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening.

Orazio Fortunato, Veronica Huber, Miriam Segale

|Mar 26, 2022
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway.

Massimo Moro, Orazio Fortunato, Giulia Bertolini

|Jun 09, 2021
Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling.

Daniela Di Paolo, Francesca Pontis, Massimo Moro

Pageof 2

Frequent Collaborators

2 joint publications

Mattia Boeri

2 joint publications

Gabriella Sozzi

1 joint publications

Mavis Mensah

1 joint publications

Cristina Borzi